GAB2 amplifications refine molecular classification of melanoma.
about
Function, regulation and pathological roles of the Gab/DOS docking proteinsGrb2-associated binding (Gab) proteins in hematopoietic and immune cell biologyStructure and function of Gab2 and its role in cancer (Review)Gab2 regulates cytoskeletal organization and migration of mammary epithelial cells by modulating RhoA activationSuperficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.Gab2 is a novel prognostic factor for colorectal cancer patientsThe potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidenceGenetic alterations in RAS-regulated pathway in acral lentiginous melanomaSimple, Sensitive and Accurate Multiplex Detection of Clinically Important Melanoma DNA Mutations in Circulating Tumour DNA with SERS Nanotags.GAB2 induces tumor angiogenesis in NRAS-driven melanoma.Docking proteins.The 11q13-q14 amplicon: clinicopathological correlations and potential drivers.Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.Clinical significance of GAB2, a scaffolding/docking protein acting downstream of EGFR in human colorectal cancer.Functional characterization of cancer-associated Gab1 mutations.Genomic characterisation of acral melanoma cell lines.Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene.Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma.GAB2 Amplification in Squamous Cell Lung Cancer of Non-Smokers.Combined detection of Gab1 and Gab2 expression predicts clinical outcome of patients with glioma.The clinical significance of c-Kit mutations in metastatic oral mucosal melanoma in China.BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.
P2860
Q21245511-DF647808-504E-47D5-BDFA-E0653782E784Q24631296-F13CE128-739C-431D-96E3-1BB12FB4B6B5Q26825507-9F681B2E-26C5-4C9A-9C65-C280C93F02A4Q30497820-A617E3CE-EC1F-4975-AA53-B107BB09A49EQ34633885-6482FA18-E626-4A17-B940-DE14924B9BAAQ34761998-2B1C1529-D205-487D-8E95-1B688BC4E7ADQ35632166-08A59645-F593-4BAE-BC1F-8702198E5194Q35810176-53C691E8-0073-4CA9-91E3-94BC3EC41D70Q36584447-7897A2F9-9026-4E7A-A67C-D297C7CE4673Q37112945-F9817FCB-25F8-4EBA-8FE1-497B946D1AF5Q37270065-10E04520-5E4A-48CB-847D-06937D72F5C6Q37795116-58AB5872-48E5-49D2-959C-2C2252A9F3C7Q38066149-8A9303C3-B564-4696-804D-50BCE572C51DQ38607710-CF2B6081-92D3-4092-96F3-728F27355FFFQ38974852-7F69CB25-37F5-4DB4-B0E8-8E8B94431975Q39321850-F96F961B-D777-424B-B296-84E193502629Q39349974-071864CD-0069-49D1-A5BB-22264FCBB3ABQ39411273-964F9E86-2276-411A-9885-3636765A76B0Q41642490-ED7891B3-1435-4289-92A7-8B7794F4FEECQ42702662-CF95E413-C9F6-4D32-B453-99613D976754Q45072058-5AB058D4-E2EE-4299-ADDF-5CC394028B91Q47098177-07B342DA-58B7-41BE-86A5-64D73E2D52F3Q47736865-92B19DCA-8989-4C3A-B11C-532488DFC909
P2860
GAB2 amplifications refine molecular classification of melanoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
GAB2 amplifications refine molecular classification of melanoma.
@ast
GAB2 amplifications refine molecular classification of melanoma.
@en
type
label
GAB2 amplifications refine molecular classification of melanoma.
@ast
GAB2 amplifications refine molecular classification of melanoma.
@en
prefLabel
GAB2 amplifications refine molecular classification of melanoma.
@ast
GAB2 amplifications refine molecular classification of melanoma.
@en
P2093
P2860
P1476
GAB2 amplifications refine molecular classification of melanoma.
@en
P2093
Basil Horst
David N Silvers
Georg Brunner
Jason A Cohen
Julide Tok Celebi
Karen A Chernoff
Katherine Simon
Keagan Lee
Lindsey Bordone
Shuang Wang
P2860
P304
P356
10.1158/1078-0432.CCR-09-0280
P407
P577
2009-06-09T00:00:00Z